Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

When effective anticancer therapies are, in fact, destabilizing the tumor's Group Phenotypic Composition.

NPJ precision oncology·2026
Same author

Evolutionary antifragile therapy is a treatment strategy to suppress drug resistance by exploiting dose response convexity.

Cancer research·2026
Same author

Mechanistic learning to predict and understand minimal residual disease.

bioRxiv : the preprint server for biology·2026
Same author

How Does Genetic Information Enable Life?

Bulletin of mathematical biology·2026
Same author

Distinct Tumor-Immune Ecologies in Patients with Lung Cancer Predict Progression and Define a Clinical Biomarker of Therapy Response.

Cancer research·2025
Same author

Polysialic Acid Presentation on Microporous Scaffolds Supports Neural Repair after Ischemic Stroke.

bioRxiv : the preprint server for biology·2025

相关实验视频

Updated: Jan 14, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.7K

放射性药物治疗和免疫治疗组合,利用癌症进化和转移性前列腺癌的计算建模.

Kimberly Luddy1, Hannah Newman2, Jordan Gravon3

  • 1Department of Immunology, Cancer Biology and Evolution Program, Moffitt Cancer Center, Magnolia Drive, Tampa, FL, USA.

PET clinics
|October 24, 2025
PubMed
概括

转移性前列腺癌耐药性通过达尔文选择进化. 像适应性疗法一样,以进化为基础的策略可以通过引导瘤生长来延迟抵抗并改善结果.

关键词:
癌症的演变 癌症的演变免疫治疗是一种免疫疗法.前列腺癌是什么意思 前列腺癌是什么意思放射性药物疗法是一种放射性药物疗法.热浪学是什么意思 热浪学进化的双重结合是进化的双重结合.

更多相关视频

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.9K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

6.5K

相关实验视频

Last Updated: Jan 14, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.7K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.9K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

6.5K

科学领域:

  • 在瘤学瘤学.
  • 进化生物学 进化生物学
  • 癌症治疗方法 癌症治疗方法

背景情况:

  • 转移性前列腺癌 (mPCa) 治疗面临着由于获得药物耐药性的挑战.
  • 持续的最大耐受剂量 (MTD) 疗法可以无意中通过达尔文选择驱动瘤进化和耐药性.
  • 了解瘤进化动态对于开发有效的mPCa治疗策略至关重要.

研究的目的:

  • 审查进化动态在转移性前列腺癌治疗中的关键作用.
  • 突出以进化为基础的治疗策略来延缓抗性.
  • 探索新疗法的潜力,如放射性药物疗法与免疫疗法结合使用.

主要方法:

  • 关于瘤进化和癌症治疗的当前文献的综述.
  • 在mPCa的背景下分析达尔文选择原理.
  • 适应性治疗和附带敏感性利用的讨论.
  • 探索放射性药物治疗和免疫治疗的组合.
  • 整合数学建模和计算机模拟以优化治疗.

主要成果:

  • 在mPCa中,瘤耐药性是一个由选择压力驱动的进化过程.
  • 适应疗法和附带敏感性策略可以引导瘤的进化,以延迟耐药性.
  • 放射性药物治疗,特别是免疫疗法,对传播的mPCa.有希望.
  • 数学模型可以优化个性化,适应性治疗方案.

结论:

  • 引导瘤进化是克服转移性前列腺癌抵抗力的关键.
  • 个性化,适应性治疗方案,以进化原则为基础,可以改善患者的治疗结果.
  • 抵抗可以从治疗失败转变为可利用的漏洞.